The North America epinephrine market is expected to reach US$ 1,598.99 Mn in 2027 from US$ 841.86 Mn in 2019. The market is estimated to grow with a CAGR of 8.5% from 2019-2027.
The growth of the market is driven by factors such as the fast growth of auto-injector production in North America and the growing prevalence of anaphylaxis cases in the North American region. Whereas, lack of availability of epinephrine drug is likely to have a negative impact on the growth of the market in the coming years.
Anaphylaxis is a severe, life‑threatening allergic reaction characterized by symptoms such as skin redness and itching, swallowing and breathing difficulties, wheezing, rapid breathing rate (tachypnoea), accelerated heart rate (tachycardia), and falling blood pressure. It may involve multiple systems of human body. Anaphylaxis is caused by exposure to an allergen (foods, insect stings, or medicines) that is recognized as a non-self by a human body.
The incidence of anaphylaxis is increasing, as per Allergy Facts by the American College of Allergy, Asthma & Immunology, and more than 50 million Americans experience different types of allergies every year. Moreover, it also lists allergies as the sixth-leading cause of chronic illness in the US and the most common health issues in children. In 2015, 8.2% of adults and 8.4% of children were diagnosed with hay fever. According to the Asthma and Allergy Foundation of America, in the last few years, hospital visits have also increased due to food allergic reaction. According to Food Allergy Research & Education, ~32 million Americans are living with life-threatening food allergies, and there are 200,000 visits to the emergency room every year due to food allergies. Allergies put an economic burden on healthcare systems in many countries; for example, according to Allergy Facts, the annual cost of managing the cases of allergies is more than USD 18 billion in the US. Anaphylaxis requires immediate medical treatment, and it can turn lethal if not treated properly. ~90–100 Americans die every year due to anaphylaxis caused by insect stings.
Therefore, the demand for epinephrine is expected to increase during the forecast period.
The rising number of the anaphylaxis cases in North America is expected to drive epinephrine market growth as Americans are more prone to allergy and infections. As in other North American countries, US faces a continuous and significant increase in the number of anaphylaxis cases. This rising number of the anaphylaxis cases and the growing pharmaceutical industry in the country create a lucrative opportunity and the presence of an established market for epinephrine.
Mexico Epinephrine Market Revenue and Forecasts to 2027 (US$ Bn)
- Sample PDF showcases the content structure and the nature of the information with qualitative and quantitative analysis.
- Request discounts available for Start-Ups & Universities
- Sample PDF showcases the content structure and the nature of the information with qualitative and quantitative analysis.
- Request discounts available for Start-Ups & Universities
NORTH AMERICA EPINEPHRINE– MARKET SEGMENTATION
North America Epinephrine Market - By Product Type
- Prefilled Syringes
- Auto-Injectors
- Ampoules and Vials
North America Epinephrine Market - By Application
- Anaphylaxis
- Superficial Bleeding
- Respiratory Disorders
- Cardiac Arrest
North America Epinephrine Market - By Distribution Channel
- Retail Pharmacies
- Hospital Pharmacies
- Online Pharmacies
North America Epinephrine Market - By Country
- US
- Canada
- Mexico
Companies Mentioned
- Mylan N.V.
- Teva Pharmaceuticals Ltd.
- Amneal Pharmaceuticals LLC
- ALK-Abelló A/S
- Abbott
- Kaleo, Inc
- BIOPROJET
- Medeca Pharma AB
- Novartis AG
- Erythpharm
Report Coverage
Revenue forecast, Company Analysis, Industry landscape, Growth factors, and Trends
Segment Covered
Product Type, Application, Distribution Channel, and Country
Regional Scope
North America, Europe, Asia Pacific, Middle East & Africa, South & Central America
Country Scope
US, Canada
1. Introduction
1.1 Scope of the Study
1.2 The Insight Partners Research Report Guidance
1.3 Market Segmentation
1.3.1 North America Epinephrine Market – By Product Type
1.3.2 North America Epinephrine Market – By Application
1.3.3 North America Epinephrine Market – By Distribution Channel
1.3.4 North America Epinephrine Market – By Country
2. North America Epinephrine Market – Key Takeaways
3. Research Methodology
3.1 Coverage
3.2 Secondary Research
3.3 Primary Research
4. North America Epinephrine Market – Market Landscape
4.1 Overview
4.2 PEST Analysis
4.2.1 Epinephrine Market - North America PEST Analysis
4.3 Expert Opinion
5. North America Epinephrine Market - Key Market Dynamics
5.1 Key Market Drivers
5.1.1 Fast growth of Auto-injector production
5.1.2 Increasing Prevalence Of Anaphylaxis Cases
5.2 Key Restraints
5.2.1 Lack of Availability of Epinephrine
5.3 Key Market Opportunities
5.3.1 Growing Pipeline of Epinephrine
5.4 Future Trend
5.4.1 Novel Drug Delivery Systems
5.5 Impact Analysis
6. Epinephrine Market – North America Analysis
6.1 North America Epinephrine Market Revenue Forecasts and Analysis
6.2 Positioning Of Key Players
7. North America Epinephrine Market Analysis And Forecasts To 2027 – Product Type
7.1 Overview
7.2 North America Epinephrine Market, By Product Type 2019 & 2027 (%)
7.2.1 North America Epinephrine Market Revenue and Forecasts to 2027, By Product Type (US$ Mn)
7.3 Auto-Injectors
7.3.1 Overview
7.3.2 North America Auto-Injectors Market Revenue and Forecast to 2027 (US$ Mn)
7.4 Prefilled Syringes
7.4.1 Overview
7.4.2 North America Prefilled Syringes Market Revenue and Forecasts to 2027 (US$ Mn)
7.5 Ampoules and Vials
7.5.1 Overview
7.5.2 North America Ampoules and Vials Market Revenue and Forecasts to 2027 (US$ Mn)
8. North America Epinephrine Market Analysis– By Application
8.1 Overview
8.2 North America Epinephrine Market, By Application 2019-2027 (%)
8.2.1 North America Epinephrine Market Revenue and Forecasts to 2027, By Application (US$ Mn)
8.3 Anaphylaxis
8.3.1 Overview
8.3.2 North America Anaphylaxis Market Revenue and Forecasts to 2027 (US$ Mn)
8.4 Cardiac Arrest
8.4.1 Overview
8.4.2 North America Cardiac Arrest Market Revenue and Forecasts to 2027 (US$ Mn)
8.5 Respiratory Disorders
8.5.1 Overview
8.5.2 North America Respiratory Disorders Market Revenue and Forecasts to 2027 (US$ Mn)
8.6 Superficial Bleeding
8.6.1 Overview
8.6.2 North America Superficial Bleeding Market Revenue and Forecasts to 2027 (US$ Mn)
9. North America Epinephrine Market Analysis– By Distribution Channel
9.1 Overview
9.2 North America Epinephrine Market, By Distribution Channel 2019-2027 (%)
9.2.1 North America Epinephrine Market Revenue and Forecasts to 2027, By Distribution Channel Application (US$ Mn)
9.3 Retail Pharmacies
9.3.1 Overview
9.3.2 North America Retail Pharmacies Market Revenue and Forecasts to 2027 (US$ Mn)
9.4 Hospital Pharmacies
9.4.1 Overview
9.4.2 North America Hospital Pharmacies Market Revenue and Forecasts to 2027 (US$ Mn)
9.5 Online Pharmacies
9.5.1 Overview
9.5.2 North America Online Pharmacies Market Revenue and Forecasts to 2027 (US$ Mn)
10. Epinephrine Market Revenue And Forecasts To 2027 Geographical Analysis
10.1 North America Epinephrine Market Revenue and Forecasts To 2027
10.1.1 Overview
10.1.2 North America Epinephrine Market, Revenue and Forecast to 2027 (US$ Mn)
10.1.3 North America Epinephrine Market, Revenue and Forecast to 2027, by Product Type (US$ Mn)
10.1.4 North America Epinephrine Market, Revenue and Forecast to 2027, by Application (US$ Mn)
10.1.5 North America Epinephrine Market, Revenue and Forecast to 2027, by Distribution Channel (US$ Mn)
10.1.6 North America Epinephrine Market, Revenue and Forecast to 2027, by Country (%)
10.1.7 United States
10.1.7.1 US Epinephrine Market, Revenue and Forecast to 2027 (US$ Mn)
10.1.7.2 US Epinephrine Market, Revenue and Forecast to 2027, by Product Type (US$ Mn)
10.1.7.3 US Epinephrine Market, Revenue and Forecast to 2027, by Application (US$ Mn)
10.1.7.4 US Epinephrine Market, Revenue and Forecast to 2027, by Distribution Channel (US$ Mn)
10.1.8 Canada
10.1.8.1 Canada Epinephrine Market, Revenue and Forecast to 2027 (US$ Mn)
10.1.8.2 Canada Epinephrine Market, Revenue and Forecast to 2027, by Product Type(US$ Mn)
10.1.8.3 Canada Epinephrine Market, Revenue and Forecast to 2027, by Application(US$ Mn)
10.1.8.4 Canada Epinephrine Market, Revenue and Forecast to 2027, by Distribution Channel (US$ Mn)
10.1.9 Mexico
10.1.9.1 Mexico Epinephrine Market, Revenue and Forecast to 2027 (US$ Mn)
10.1.9.2 Mexico Epinephrine Market, Revenue and Forecast to 2027, by Product Type(US$ Mn)
10.1.9.3 Mexico Epinephrine Market, Revenue and Forecast to 2027, by Application(US$ Mn)
10.1.9.4 Mexico Epinephrine Market, Revenue and Forecast to 2027, by Distribution Channel (US$ Mn)
11. North America Epinephrine Market –Industry Landscape
11.1 Overview
11.2 Growth Strategies In The Epinephrine Market, 2015-2019
11.3 Organic Growth Strategies
11.3.1 Overview
11.4 Inorganic Growth Strategies
11.4.1 Overview
11.5 Intranasal Epinephrine Spray–Clinical Trials
11.5.1 Overview
12. North America Epinephrine Market- Key Company Profiles
12.1 ALK-Abelló A/S
12.1.1 Key Facts
12.1.2 Business Description
12.1.3 Products and Services
12.1.4 Overview
12.1.5 SWOT Analysis
12.1.6 Key Developments
12.2 Abbott
12.2.1 Key Facts
12.2.2 Business Description
12.2.3 Products and Services
12.2.4 Financial Overview
12.2.5 SWOT Analysis
12.2.6 Key Developments
12.3 Amneal Pharmaceuticals, Inc.
12.3.1 Key Facts
12.3.2 Business Description
12.3.3 Products and Services
12.3.4 Financial Overview
12.3.5 SWOT Analysis
12.3.6 Key Developments
12.4 Kaleo, Inc.
12.4.1 Key Facts
12.4.2 Business Description
12.4.3 Products and Services
12.4.4 Financial Overview
12.4.5 SWOT Analysis
12.4.6 Key Developments
12.5 Teva Pharmaceutical Industries Ltd
12.5.1 Key Facts
12.5.2 Business Description
12.5.3 Products and Services
12.5.4 Financial Overview
12.5.5 SWOT Analysis
12.5.6 Key Developments
12.6 BIOPROJET
12.6.1 Key Facts
12.6.2 Business Description
12.6.3 Products and Services
12.6.4 Financial Overview
12.6.5 SWOT Analysis
12.6.6 Key Developments
12.7 Medeca Pharma AB
12.7.1 Key Facts
12.7.2 Business Description
12.7.3 Products and Services
12.7.4 Financial Overview
12.7.5 SWOT Analysis
12.7.6 Key Developments
12.8 Novartis AG
12.8.1 Key Facts
12.8.2 Business Description
12.8.3 Products and Services
12.8.4 Financial Overview
12.8.5 SWOT Analysis
12.8.6 Key Developments
12.9 MYLAN N.V.
12.9.1 Key Facts
12.9.2 Business Description
12.9.3 Products and Services
12.9.4 Financial Overview
12.9.5 SWOT Analysis
12.9.6 Key Developments
12.10 Erythpharm
12.10.1 Key Facts
12.10.2 Business Description
12.10.3 Products and Services
12.10.4 Financial Overview
12.10.5 SWOT Analysis
12.10.6 Key Developments
13. Appendix
13.1 About The Insight Partners
13.2 Glossary of Terms
LIST OF TABLES
Table 1. North America Epinephrine Market Revenue and Forecasts To 2027, By Product Type (US$ Mn)
Table 2. North America Epinephrine Market Revenue and Forecasts To 2027, By Application (US$ Mn)
Table 3. North America Epinephrine Market Revenue and Forecasts To 2027, By Distribution Channel (US$ Mn)
Table 4. North America Epinephrine Market, Revenue and Forecast to 2027, by Product Type(US$ Mn)
Table 5. North America Epinephrine Market, Revenue and Forecast to 2027, by Application (US$ Mn)
Table 6. North America Epinephrine Market, Revenue and Forecast to 2027, by Distribution Channel (US$ Mn)
Table 7. US Epinephrine Market Revenue and Forecast To 2027, by Product Type(US$ Mn)
Table 8. US Epinephrine Market, Revenue and Forecast To 2027, by Application (US$ Mn)
Table 9. US Epinephrine Market, Revenue and Forecast To 2027, by Distribution Channel (US$ Mn)
Table 10. Canada Epinephrine Market Revenue and Forecast To 2027, by Product Type (US$ Mn)
Table 11. Canada Epinephrine Market Revenue and Forecast To 2027, by Application (US$ Mn)
Table 12. Canada Epinephrine Market, Revenue and Forecast To 2027, by Distribution Channel (US$ Mn)
Table 13. Mexico Epinephrine Market Revenue and Forecast To 2027, by Product Type (US$ Mn)
Table 14. Mexico Epinephrine Market Revenue and Forecast To 2027, by Application (US$ Mn)
Table 15. Mexico Epinephrine Market, Revenue and Forecast To 2027, by Distribution Channel (US$ Mn)
Table 16. Recent Organic Growth Strategies in the Epinephrine market
Table 17. Recent Inorganic Growth Strategies In The Epinephrine Market
Table 18. Developments For The Intranasal Epinephrine Spray, By Companies
Table 19. Glossary of Terms, Epinephrine Market
LIST OF FIGURES
Figure 1. Epinephrine Market Segmentation
Figure 2. North America Epinephrine Market Overview
Figure 3. Auto-injectors Segment Held Largest Share Of Product type Segment In Epinephrine Market
Figure 4. North America Epinephrine Market- Leading Country Markets (US$ Mn)
Figure 5. North America Epinephrine Market, Industry Landscape
Figure 6. Epinephrine Market - North America PEST Analysis
Figure 7. Epinephrine Market Impact Analysis of Drivers And Restraints
Figure 8. North America Epinephrine Market – Revenue Forecasts and Analysis – 2019- 2027
Figure 9. Market Positioning Of Key Players In North America Epinephrine Market
Figure 10. North America Epinephrine Market, by Product Type 2019 & 2027 (%)
Figure 11. North America Auto-Injectors Market Revenue and Forecasts to 2027 (US$ Mn)
Figure 12. North America Prefilled Syringes Market Revenue and Forecasts to 2027 (US$ Mn)
Figure 13. North America Ampoules and Vials Market Revenue and Forecasts to 2027 (US$ Mn)
Figure 14. North America Epinephrine Market, by Application 2019 & 2027 (%)
Figure 15. North America Anaphylaxis Market Revenue and Forecasts to 2027 (US$ Mn)
Figure 16. North America Cardiac Arrest Market Revenue and Forecasts to 2027 (US$ Mn)
Figure 17. North America Respiratory Disorders Market Revenue and Forecasts to 2027 (US$ Mn)
Figure 18. North America Superficial Bleeding Market Revenue and Forecasts to 2027 (US$ Mn)
Figure 19. North America Epinephrine Market, by Distribution Channel 2019 & 2027 (%)
Figure 20. North America Retail Pharmacies Market Revenue and Forecasts to 2027 (US$ Mn)
Figure 21. North America Hospital Pharmacies Market Revenue and Forecasts to 2027 (US$ Mn)
Figure 22. North America Online Pharmacies Market Revenue and Forecasts to 2027 (US$ Mn)
Figure 23. North America Epinephrine Market, Revenue by Country (2019) (US$ Mn)
Figure 24. North America Epinephrine Market Revenue and Forecast to 2027 (US$ Mn)
Figure 25. North America Epinephrine Market, Revenue and Forecast to 2027, by Country (%)
Figure 26. US Epinephrine Market, Revenue and Forecast to 2027 (US$ Mn)
Figure 27. Canada Epinephrine Market, Revenue and Forecast to 2027 (US$ Mn)
Figure 28. Mexico Epinephrine Market, Revenue and Forecast to 2027 (US$ Mn)
Figure 29. Growth Strategies In The Epinephrine Market, 2015-2019
The List of Companies - North America Epinephrine Market
- Mylan N.V.
- Teva Pharmaceuticals Ltd.
- Amneal Pharmaceuticals LLC
- ALK-Abelló A/S
- Abbott
- Kaleo, Inc
- BIOPROJET
- Medeca Pharma AB
- Novartis AG
- Erythpharm
The Insight Partners performs research in 4 major stages: Data Collection & Secondary Research, Primary Research, Data Analysis and Data Triangulation & Final Review.
- Data Collection and Secondary Research:
As a market research and consulting firm operating from a decade, we have published many reports and advised several clients across the globe. First step for any study will start with an assessment of currently available data and insights from existing reports. Further, historical and current market information is collected from Investor Presentations, Annual Reports, SEC Filings, etc., and other information related to company’s performance and market positioning are gathered from Paid Databases (Factiva, Hoovers, and Reuters) and various other publications available in public domain.
Several associations trade associates, technical forums, institutes, societies and organizations are accessed to gain technical as well as market related insights through their publications such as research papers, blogs and press releases related to the studies are referred to get cues about the market. Further, white papers, journals, magazines, and other news articles published in the last 3 years are scrutinized and analyzed to understand the current market trends.
- Primary Research:
The primarily interview analysis comprise of data obtained from industry participants interview and answers to survey questions gathered by in-house primary team.
For primary research, interviews are conducted with industry experts/CEOs/Marketing Managers/Sales Managers/VPs/Subject Matter Experts from both demand and supply side to get a 360-degree view of the market. The primary team conducts several interviews based on the complexity of the markets to understand the various market trends and dynamics which makes research more credible and precise.
A typical research interview fulfils the following functions:
- Provides first-hand information on the market size, market trends, growth trends, competitive landscape, and outlook
- Validates and strengthens in-house secondary research findings
- Develops the analysis team’s expertise and market understanding
Primary research involves email interactions and telephone interviews for each market, category, segment, and sub-segment across geographies. The participants who typically take part in such a process include, but are not limited to:
- Industry participants: VPs, business development managers, market intelligence managers and national sales managers
- Outside experts: Valuation experts, research analysts and key opinion leaders specializing in the electronics and semiconductor industry.
Below is the breakup of our primary respondents by company, designation, and region:
Once we receive the confirmation from primary research sources or primary respondents, we finalize the base year market estimation and forecast the data as per the macroeconomic and microeconomic factors assessed during data collection.
- Data Analysis:
Once data is validated through both secondary as well as primary respondents, we finalize the market estimations by hypothesis formulation and factor analysis at regional and country level.
- 3.1 Macro-Economic Factor Analysis:
We analyse macroeconomic indicators such the gross domestic product (GDP), increase in the demand for goods and services across industries, technological advancement, regional economic growth, governmental policies, the influence of COVID-19, PEST analysis, and other aspects. This analysis aids in setting benchmarks for various nations/regions and approximating market splits. Additionally, the general trend of the aforementioned components aid in determining the market's development possibilities.
- 3.2 Country Level Data:
Various factors that are especially aligned to the country are taken into account to determine the market size for a certain area and country, including the presence of vendors, such as headquarters and offices, the country's GDP, demand patterns, and industry growth. To comprehend the market dynamics for the nation, a number of growth variables, inhibitors, application areas, and current market trends are researched. The aforementioned elements aid in determining the country's overall market's growth potential.
- 3.3 Company Profile:
The “Table of Contents” is formulated by listing and analyzing more than 25 - 30 companies operating in the market ecosystem across geographies. However, we profile only 10 companies as a standard practice in our syndicate reports. These 10 companies comprise leading, emerging, and regional players. Nonetheless, our analysis is not restricted to the 10 listed companies, we also analyze other companies present in the market to develop a holistic view and understand the prevailing trends. The “Company Profiles” section in the report covers key facts, business description, products & services, financial information, SWOT analysis, and key developments. The financial information presented is extracted from the annual reports and official documents of the publicly listed companies. Upon collecting the information for the sections of respective companies, we verify them via various primary sources and then compile the data in respective company profiles. The company level information helps us in deriving the base number as well as in forecasting the market size.
- 3.4 Developing Base Number:
Aggregation of sales statistics (2020-2022) and macro-economic factor, and other secondary and primary research insights are utilized to arrive at base number and related market shares for 2022. The data gaps are identified in this step and relevant market data is analyzed, collected from paid primary interviews or databases. On finalizing the base year market size, forecasts are developed on the basis of macro-economic, industry and market growth factors and company level analysis.
- Data Triangulation and Final Review:
The market findings and base year market size calculations are validated from supply as well as demand side. Demand side validations are based on macro-economic factor analysis and benchmarks for respective regions and countries. In case of supply side validations, revenues of major companies are estimated (in case not available) based on industry benchmark, approximate number of employees, product portfolio, and primary interviews revenues are gathered. Further revenue from target product/service segment is assessed to avoid overshooting of market statistics. In case of heavy deviations between supply and demand side values, all thes steps are repeated to achieve synchronization.
We follow an iterative model, wherein we share our research findings with Subject Matter Experts (SME’s) and Key Opinion Leaders (KOLs) until consensus view of the market is not formulated – this model negates any drastic deviation in the opinions of experts. Only validated and universally acceptable research findings are quoted in our reports.
We have important check points that we use to validate our research findings – which we call – data triangulation, where we validate the information, we generate from secondary sources with primary interviews and then we re-validate with our internal data bases and Subject matter experts. This comprehensive model enables us to deliver high quality, reliable data in shortest possible time.
Trends and growth analysis reports related to North America Epinephrine Market
Mar 2020
Aquatic Veterinary Market
Size and Forecast (2020 - 2030), Global and Regional Share, Trend, and Growth Opportunity Analysis Report Coverage: By Type (Diagnostics and Treatments), Species (Fish, Crustaceans, Mollusca, and Others), Disease Source (Bacteria, Viruses, Parasites, and Others), Route of Administration (Water Medication, Medicated Feed, and Others), and Geography (North America, Europe, Asia Pacific, Middle East & Africa, and South & Central America)
Mar 2020
Sickle Cell Disease Treatment Market
Size and Forecasts (2020 - 2030), Global and Regional Share, Trends, and Growth Opportunity Analysis By Treatment (Generic Drugs and Originators), Route of Administration (Oral and Parenteral), and Distribution Channel (Direct Tender, Hospital Pharmacies, Retail Pharmacies, Online Pharmacies, and Others)
Mar 2020
Malaria and Sickle Cell Disease Treatment Market
Size and Forecasts (2020 - 2030), Global and Regional Share, Trends, and Growth Opportunity Analysis Report Coverage: By Treatment [Malaria and Sickle Cell Disease (SCD)], Route of Administration (Oral and Parenteral), and Distribution Channel (Direct Tender, Hospital Pharmacies, Retail Pharmacies, Online Pharmacies, and Others)
Mar 2020
Pharmaceutical Contract Sales Organizations Market
Size and Forecasts (2020 - 2030), Global and Regional Share, Trends, and Growth Opportunity Analysis Report Coverage: By Services (Commercial Services and Non-Commercial Services), Modules (Syndicated Modules and Dedicated Modules), Therapeutic Area (Cardiovascular Disorders, Oncology, Metabolic Disorders, Neurology, Orthopedic Diseases, Infectious Diseases, and Others), End User (Biopharmaceutical Companies and Pharmaceutical Companies), and Geography (North America, Europe, Asia Pacific, Middle East & Africa, and South & Central America)
Mar 2020
Breast Cancer Therapeutics Market
Size and Forecasts (2020 - 2030), Global and Regional Share, Trends, and Growth Opportunity Analysis Report Coverage: By Drug Therapy [Targeted Drug Therapy (Abemaciclib, Ado-Trastuzumab Emtansine, Palbociclib, Trastuzumab, and Other Target Drug Therapies), Hormonal Drug Therapy (Selective Estrogen Receptor Modulators, Aromatase Inhibitors, and Selective Estrogen Receptor Downregulators), Chemotherapy, and Immunotherapy/Biological Therapy], Breast Cancer Type (Hormone Receptor, HER2+, and Triple-Negative Breast Cancer), Distribution Channel (Hospital Pharmacies, Drug Stores and Retail Pharmacies, and Online Pharmacies), and Geography (North America, Europe, Asia Pacific, Middle East & Africa, and South & Central America)
Mar 2020
Radioactive Tracer Market
Size and Forecast to 2030 - Global Analysis by Tracer Type [Technetium-99m & Tc-97m, Iodine-131, Iron-59, Lutetium-171, Rubidium (Rb-82) Chloride & Ammonia (N-13), Scandium-46, Seaborgium-269, Hassium-269, Gallium Citrate Ga 67, Prostate-Specific Membrane Antigen (PSMA) (Ga-68), FDDNP (F-18) & FDOPA (F-18), Phosphorus-32 & Chromium-51, Thallium-201, F-18 FDG, F-18 FAPI, Ga-68 FAPI, F-18 PSMA, DOTATOC/DOTANOC/DOTATATE (Ga-68), and Others], Test Type (PET, SPECT, and Others), Application (Oncology, Pulmonary, Neurology, Cardiology, and Others) End User (Hospitals & Clinics, Diagnostic Centers, Academic & Research Institutes, And Others), and Geography
Mar 2020
Glioma Treatment Market
Size and Forecasts (2020 - 2030), Global and Regional Share, Trends, and Growth Opportunity Analysis Report Coverage: By Disease (Astrocytoma, Oligoastrocytoma, and Oligodendroglioma), Treatment Type (Surgery, Chemotherapy, Radiation Therapy, and Others), Grade (Low Grade and High Grade), End User (Hospital & Clinics and Ambulatory Surgical Center), and Geography
Mar 2020
Hyperpigmentation Disorder Treatment Market
Size and Forecast (2020 - 2030), Global and Regional Share, Trend, and Growth Opportunity Analysis Report Coverage: By Treatment Type (Cosmeceutical, Light or Laser Therapy, Microdermabrasion, Chemical Peels, Cryotherapy, and Others), Condition (Melasma, Solar Lentigines, Post-Inflammatory Hyperpigmentation, and Others), End User (Hospitals, Dermatology Centers, and Others), and Geography (North America, Europe, Asia Pacific, South & Central America, and Middle East & Africa)